Josep Dalmau (f. 1953) er professor (research professor) ved ICREA-IDIBAPS, Hospital Clinic, University of Barcelona, og professor (adjunct professor) i nevrologi ved Department of Neurology, University of Pennsylvania og har nevroimmunologi som spesialfelt.
Forfatter har fylt ut ICMJE-skjemaet og oppgir følgende interessekonflikter: Han mottar royalties fra Up-To-Date, og fra patenter for benyttelse av Ma2 og NMDA-reseptor i antistoffanalyser. Han har mottatt stipend fra Euroimmun, The National Institute of Health (RO1NS077851 og RO1MH094741), The National Cancer Institute (RO1CA89054), og Fundació la Marató de TV3 og McKnight Neuroscience of Brain Disorders Award.
Petter Strømme (f. 1951) er spesialist i barnesykdommer, overlege og professor med nevrodegenerasjon og genetiske årsaker til utviklingshemning som interessefelt.
Forfatter har fylt ut ICMJE-skjemaet og oppgir ingen interessekonflikter.
Dalmau J, Tüzün E, Wu HY et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61: 25 – 36. [PubMed] [CrossRef]
8.
Lancaster E, Martinez-Hernandez E, Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology 2011; 77: 179 – 89. [PubMed] [CrossRef]
9.
Granerod J, Ambrose HE, Davies NWS et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010; 10: 835 – 44. [PubMed] [CrossRef]
10.
Iizuka T, Sakai F, Ide T et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 2008; 70: 504 – 11. [PubMed] [CrossRef]
11.
Dalmau J, Lancaster E, Martinez-Hernandez E et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011; 10: 63 – 74. [PubMed] [CrossRef]
Wandinger KP, Saschenbrecker S, Stoecker W et al. Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol 2011; 231: 86 – 91. [PubMed] [CrossRef]
14.
Dalmau J, Gleichman AJ, Hughes EG et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7: 1091 – 8. [PubMed] [CrossRef]
15.
Florance NR, Davis RL, Lam C et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009; 66: 11 – 8. [PubMed] [CrossRef]
16.
Pavone P, Pettoello-Mantovano M, Le Pira A et al. Acute disseminated encephalomyelitis: a long-term prospective study and meta-analysis. Neuropediatrics 2010; 41: 246 – 55. [PubMed] [CrossRef]
17.
Vincent A, Bien CG, Irani SR et al. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 2011; 10: 759 – 72. [PubMed] [CrossRef]
18.
Nasky KM, Knittel DR, Manos GH. Psychosis associated with anti-N-methyl-D-aspartate receptor antibodies. CNS Spectr 2008; 13: 699 – 703. [PubMed]
19.
Neuhut R, Lindenmayer JP, Silva R. Neuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication: a review. J Child Adolesc Psychopharmacol 2009; 19: 415 – 22. [PubMed] [CrossRef]
20.
Dale RC, Irani SR, Brilot F et al. N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol 2009; 66: 704 – 9. [PubMed] [CrossRef]
21.
Creten C, van der Zwaan S, Blankespoor RJ et al. Late onset autism and anti-NMDA-receptor encephalitis. Lancet 2011; 378: 98. [PubMed] [CrossRef]
22.
Finke C, Kopp UA, Prüss H et al. Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry 2012; 83: 195 – 8. [PubMed] [CrossRef]
Får du ikke vist PDF-filen eller vil lagre filen, kan du høyreklikke på PDF-ikonet. Velg «Lagre mål/fil som..» og hent så opp PDF-filen i for eksempel Acrobat Reader.